Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Keynote Address: Building global trust through science, speed, and transparency
At the recently held Ahmedabad Pharma Summit 2025, Dr HG Koshia, Commissioner, Food & Drugs Control Administration (FDCA),…
Biocon Biologics gains market access coverage for Yesintek in the US
Yesintek is a biosimilar to Stelara (ustekinumab) and is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque…
How counterfeiters are breaching India’s QR code system
If the QR code system is not all that it was promised to be, what are the next steps to safeguard our medicines?
Cell and gene therapy market projected to grow at 31.3% CAGR through 2030
Significant advancements in treatments for dermatology disorders are anticipated, driven by innovations from both small to…
Reshaping investigations in the pharma industry: Ensuring compliance under the DPDP Act
Sahil Kanuga and Sara Sundaram urge fostering a culture of data protection to ensure that investigations in pharmaceutical and…
Pharma M&A deal value surges by 101% in Q1 2025 despite US political turbulence
According to GlobalData’s report, oncology remains the leading therapeutic area in Q1 2025, with most of the deals targeting…
Express Pharma May 2025
India's Foremost Pharma & Biotech Magazine ~ Charting The Global Evolution of Indian Pharma
AI expected to transform life sciences operations, says KPMG global tech report 2024
KPMG report finds 73 per cent of life sciences tech leaders believe AI will drive efficiency and new business models
Strides Pharma receives USFDA approval for Celecoxib Capsules in multiple strengths
Approval from USFDA allows Strides Pharma to market Celecoxib Capsules 100 mg, 200 mg, and 400 mg in the United States
Alembic Pharmaceuticals receives US FDA EIR for Panelav oncology facility
US FDA inspection for injectable and oral solid formulation unit conducted in October 2024 has been successfully closed